Skip to content

Non Grafted Maxillary Sinus Floor Elevation With Implant Placement Versus the Use of Short Endosseous Implants

Non Grafted Maxillary Sinus Floor Elevation With Simultaneous Implant Placement Versus the Use of Short Endosseous Implants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03661957
Enrollment
10
Registered
2018-09-07
Start date
2018-09-30
Completion date
2019-04-30
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marginal Bone Loss, Primary Stability of Implants

Brief summary

Assessment the need for sinus floor elevation when restoring atrophic posterior maxilla or it will be enough to use of short implant

Interventions

PROCEDURENon grafted maxillary sinus floor elevation with simultaneous implant placement

lateral window for sinus elevation ,membrane elevation ,implant placement , membrane for window closure

PROCEDUREusing short dental implants for posterior atrophic maxilla

placement of short dental implant with bone height below 8mm

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with partially edentulous in the posterior area of the maxilla, with a residual ridge that allowed insertion of ≤8 mm length implants. * Both sexes. * No intraoral soft and hard tissue pathology * No systemic condition that contraindicate implant placement.

Exclusion criteria

* Sinus pathology. * Heavy smokers more than 20 cigarettes per day. * Patients with systemic disease that may affect normal healing. * Psychiatric problems * Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site * Immunodeficiency pathology, bruxism, stress situation (socially or professionally), emotional instability, and unrealistic aesthetic demands.

Design outcomes

Primary

MeasureTime frameDescription
primary stability6 monthsmeasuring primary stability using osstel

Secondary

MeasureTime frameDescription
marginal bone loss6 monthsmeasuring marginal bone loss using cone beam ct

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026